07.27.2015
Prevent & Delay
$280,151.00
24 months
Reversing Type 1 Diabetes After it is Established: Follow up, Phase II
Funding to support a three-year follow-up of a cohort with long-standing type 1 diabetes who participated in a clinical trial using a combination of two FDA-approved immunosuppressant drugs.